Susan C. Low - Concepedia

Author

Susan C. Low

Biogen (United States)

Also Known As

Susan C Low, Susan C. Low, Susan Low

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Biogen (United States)Harvard University Brigham and Women's Hospital University of North Carolina at Chapel Hill The Barbara Ann Karmanos Cancer Institute

About

Susan C. Low is an author at Biogen (United States) specializing in medicine, pharmacology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	669
2	Engineering	2	2	123
3	Natural Sciences	2	2	457
4	Biochemistry	2	2	457
5	Public Health	1	1	42

Susan C. Low

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile Jeffrey S. Hrkach, Daniel D. Von Hoff, Mir Mukkaram Ali, Science Translational Medicine	2012	1.1K
Knowing when not to stop: selenocysteine incorporation in eukaryotes Susan C. Low, Marla J. Berry Trends in Biochemical Sciences Selenocysteine IncorporationCellular EnzymologyBiochemistryCell DivisionNatural Sciences	1996	433
Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors Daniel D. Von Hoff, Monica Mita, Ramesh K. Ramanathan, Clinical Cancer Research	2016	262
Design and testing of a humanized porcine donor for xenotransplantation R. Anand, Jacob V. Layer, Dávid Héja, Nature	2023	235
Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway Alan J. Bitonti, Jennifer Dumont, Susan C. Low, Proceedings of the National Academy of Sciences	2004	227
Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo Susan Ashton, Young Ho Song, Elaine Cadogan, Science Translational Medicine	2016	213
Prolonged activity of factor IX as a monomeric Fc fusion protein Robert Peters, Susan C. Low, George D. Kamphaus, Blood	2010	191
Cloning and Functional Characterization of Human Selenophosphate Synthetase, an Essential Component of Selenoprotein Synthesis Susan C. Low, John W. Harney, Marla J. Berry Journal of Biological Chemistry	1995	185
Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs Jennifer Dumont, Tongyao Liu, Susan C. Low, Blood	2012	153
Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn Adam R. Mezo, Kevin McDonnell, Cristina A. Tan Hehir, Proceedings of the National Academy of Sciences	2008	101

Page 1